Constantine Xykis
CIK 1852699 · View on SEC EDGAR ↗
First SEC filing: March 25, 2021 · Latest: March 25, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 9, 2025 | PSIX | S | 7,854 | $91.31 | $717,149 | 0 Direct | -100.00% | Disposed | -59.5% (price as of 2026-08-20) |
| Aug. 12, 2025 | PSIX | S | 13,027 | $96.20 | $1,253,197 | 7,854 Direct | -62.39% | Disposed | -61.6% (price as of 2026-08-20) |
| Aug. 12, 2025 | PSIX | S | 12,978 | $95.50 | $1,239,399 | 20,881 Direct | -38.33% | Disposed | -61.3% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 18, 2025 | PSIX | Stock Appreciation Rights | Common Stock | $2.99 | April 25, 2033 | 14,996 | Disposed |
| June 11, 2025 | PSIX | Stock Appreciation Rights | Common Stock | $2.99 | April 25, 2033 | 35,000 | Disposed |
| June 2, 2025 | PSIX | Stock Appreciation Rights | Common Stock | $2.99 | April 25, 2033 | 6,670 | Disposed |
| June 2, 2025 | PSIX | Stock Appreciation Rights | Common Stock | $2.99 | April 25, 2033 | 16,663 | Disposed |
| May 30, 2025 | PSIX | Stock Appreciation Rights | Common Stock | $2.99 | April 25, 2033 | 6,670 | Disposed |
| May 30, 2025 | PSIX | Stock Appreciation Rights | Common Stock | $2.99 | April 25, 2033 | 16,663 | Disposed |
| Oct. 1, 2024 | PSIX | Stock Appreciation Rights | Common Stock | $6.50 | March 18, 2032 | 342 | Disposed |
| Oct. 1, 2024 | PSIX | Stock Appreciation Rights | Common Stock | $6.82 | March 11, 2031 | 25,000 | Disposed |
| Oct. 1, 2024 | PSIX | Stock Appreciation Rights | Common Stock | $11.25 | Feb. 22, 2026 | 1,500 | Disposed |
| May 15, 2024 | PSIX | Stock Appreciation Rights | Common Stock | $2.00 | April 25, 2033 | 20,000 | Disposed |
| April 25, 2023 | PSIX | Stock Appreciation Rights | Common Stock | $2.99 | April 25, 2023 | 85,000 | Acquired |
| April 25, 2023 | PSIX | Stock Appreciation Rights | Common Stock | $2.99 | April 25, 2033 | 85,000 | Acquired |
| April 25, 2023 | PSIX | Stock Appreciation Rights | Common Stock | $2.99 | April 25, 2033 | 16,663 | Acquired |
| July 15, 2022 | PSIX | Stock Appreciation Rights | Common Stock | $2.00 | July 15, 2032 | 20,000 | Acquired |
| March 18, 2022 | PSIX | Stock Appreciation Right | Common Stock | $6.50 | March 18, 2032 | 342 | Acquired |
| March 11, 2021 | PSIX | Stock Appreciation Right | Common Stock (25,000) | $6.50 | March 11, 2031 | 25,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $598,276 | $816,790 | — | — | — | — | — | $2,425,216 |
| 2024 | $539,846 | $71,985 | — | — | $534,674 | — | $62,728 | $1,209,233 |
| 2023 | $472,692 | $317,681 | — | — | $383,827 | — | $58,540 | $1,449,282 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.